Contractubex® works deep inside the skin, and reduces scars thanks to its
pharmacologically active ingredients (extractum cepae, heparin & allantoin).
The Contractubex® lasting triple effect means:
- Prevention of excessive scar tissue formation5
- Reduction in redness, itching and the feeling of tension6,12
- Lasting improvement of scar appearance5
For best possible results, treatment should be started as soon as the wound is closed or the stitches are removed. Contractubex® – for nearly invisible scars.
Silicone
- Silicone foil has been used to cover wounds to reduce scarring since 1981.1
- A meta-analysis of studies conducted on the effectiveness of silicone foil concluded that the data from 15 studies were unconvincing.1
- A recent study showed no long-term advantage of silicone spray treatment in the appearance of scars. At a follow-up time point several months after the end of treatment, the normal wound-healing process taking place in the placebo-treated control scars resulted in an equally good appearance as seen in the silicone-treated scar.2
- Hydration and occlusion do aid scar-healing, but there is no evidence that silicone aids this process.3
Contractubex®
- Scar tissue has been treated successfully with Contractubex® since 1959. Contractubex® is the world’s No. 1 scar treatment.4
- The active ingredients in Contractubex® promote the healing process with the triple effect, which prevents excessive scar tissue formation, reduce redness, itching and the feeling of tension, and makes the scar smoother and improves elasticity.5, 6
- Controlled trials on burns, hypertrophic scars, keloids, skin-grafts and scars after pediatric thorax surgery plus numerous observational studies demonstrate the reliable efficacy of Contractubex®.5 – 9
- Even scars that are several years old may improve visibly after treatment including Contractubex®.10
1 O’Brien L, Pandit A, Cochrane Database of Systematic Reviews 2006, Issue 1
2 Stoffels I et al., Der Hautarzt 2010; 61: 332 – 338
3 Atiyeh B, Aesth Plast Surg 2007; 31: 468 – 492
4 IMS Global Pharmacy Data (Value) 2011
5 Maragakis M et al., Drugs Exp Clin Res 1995; 21: 199 – 206
6 Willital GH, Simon J, Kompendium Dermatologie 2007; 3: 16 – 20.
Pictures data on file.
7 Chadzynska M et al., Dt. Derm. 1989; 37: 1288 – 1299
8 Willital GH et al., Int. J. Clin. Pharmacol. 1994; 14: 193 – 202
9 Dyakov R et al., Ann. of Burns and Fire Disasters 2002; 15: 70 – 74
10 Danneberg DJ, Kosmetische Medizin 2007; 3: 24 – 29
11 Koc E et al., Dermatol Surg 2008; 34: 1 – 8
12 Beuth J et al., In Vivo 2006; 20: 277 – 284
13 Ho WS et al., Dermatol Surg 2006; 32: 891 – 896